Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease

Citation
Y. Matsuoka et al., Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease, AM J PATH, 158(4), 2001, pp. 1345-1354
Citations number
34
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF PATHOLOGY
ISSN journal
00029440 → ACNP
Volume
158
Issue
4
Year of publication
2001
Pages
1345 - 1354
Database
ISI
SICI code
0002-9440(200104)158:4<1345:IRTAIA>2.0.ZU;2-I
Abstract
Mutations in the amyloid precursor protein (APP) and presenilin-1 and -2 ge nes (PS-I, -2) cause Alzheimer's disease (AD), Mice carrying both mutant ge nes (PS/APP) develop AD-like deposits composed of beta -amyloid (A beta) at an early age. In this study, we have examined how A beta deposition is ass ociated with immune responses. Both fibrillar and nonfibrillar A beta (diff use) deposits were visible in the frontal cortex by 3 months, and the amylo id load increased dramatically with age. The number of fibrillar A beta dep osits increased up to the oldest age studied (2.5 years old), whereas there were less marked changes in the number of diffuse deposits in mice over 1 year old. Activated microglia and astrocytes increased synchronously with a myloid burden and were, in general, closely associated with deposits. Cyclo oxygenase-2, an inflammatory response molecule involved in the prostaglandi n pathway, was up-regulated in astrocytes associated with some fibrillar de posits. Complement component Iq, an immune response component, strongly col ocalized with fibrillar A beta, but was also up-regulated in some plaque-as sociated microglia These results show: i) an increasing proportion of amylo id is composed of frbrillar A beta in the aging PS/APP mouse brain; ii) mic roglia and astrocytes are activated by both fibrillar and diffuse A beta; a nd iii) cyclooxygenase-a and complement component 1q levels increase in res ponse to the formation of fibrillar A beta in PS/APP mice.